These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3473590)

  • 21. Muscarinic receptors: ionic perturbation of the binding properties [proceedings].
    Birdsall NJ; Burgen AS; Hulme EC; Wells JW
    Br J Pharmacol; 1977 Mar; 59(3):503P. PubMed ID: 843741
    [No Abstract]   [Full Text] [Related]  

  • 22. [Muscarinic receptors].
    Burgen AS
    Actual Pharmacol (Paris); 1977; 29():143-54. PubMed ID: 868615
    [No Abstract]   [Full Text] [Related]  

  • 23. Apparent activity of 5-methylfurmethide at muscarinic receptors.
    Ochillo RF
    Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):69-75. PubMed ID: 7212878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical characterization of muscarinic receptors: multiplicity of binding components.
    Massoulié J; Carson S; Kato G
    Prog Brain Res; 1979; 49():303-11. PubMed ID: 390608
    [No Abstract]   [Full Text] [Related]  

  • 25. The theory, methods and relevance of muscarinic receptor binding studies.
    Stockton J; Birdsall NJ; Burgen AS; Hulme EC
    Scand J Gastroenterol Suppl; 1982; 72():43-7. PubMed ID: 6957996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Affinity, efficacy, and stereoselectivity of oxotremorine analogues for muscarinic receptors in the isolated guinea pig ileum.
    Ringdahl B; Jenden DJ
    Mol Pharmacol; 1983 Jan; 23(1):17-25. PubMed ID: 6135142
    [No Abstract]   [Full Text] [Related]  

  • 27. Cholinergic receptors in the mammalian central nervous system.
    Yamamura HI; Wastek G; Chang KJ; Snyder SH
    Proc West Pharmacol Soc; 1976; 19():13-8. PubMed ID: 995977
    [No Abstract]   [Full Text] [Related]  

  • 28. Altered ontogenesis of muscarinic receptors in agranular cerebellar cortex.
    Soreq H; Gurwitz D; Eliyahu D; Sokolovsky M
    J Neurochem; 1982 Sep; 39(3):756-63. PubMed ID: 7097282
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of first and second generation antidepressants at the human muscarinic cholinergic receptor.
    Tollefson GD; Senogles SE
    J Clin Psychopharmacol; 1983 Aug; 3(4):231-4. PubMed ID: 6886034
    [No Abstract]   [Full Text] [Related]  

  • 30. [Structure-activity relationship in the series of muscarinic acetylcholine receptor antagonists: four types of antagonist-receptor binding].
    Tropsha AE; Nizhniĭ SV; Iaguzhinskiĭ LS
    Bioorg Khim; 1985 Oct; 11(10):1402-16. PubMed ID: 4074400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atropine and mepenzolate mydriasis in rabbits: a comparative pupillographic analysis of two antimuscarinic agents.
    Ochillo RF; Pugh DA
    Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):503-6. PubMed ID: 7122991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Electrophysiologic study of the properties of the cholinoreceptors of frog sympathetic ganglion neurons].
    Trinus KF
    Neirofiziologiia; 1979; 11(5):475-82. PubMed ID: 514410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Possibility of substance selective action on the m-cholinoreceptors of a specific site].
    Kharkevich DA; Skoldinov AP; Samăilov DN; Shorr VA
    Farmakol Toksikol; 1980; 43(6):645-52. PubMed ID: 7449999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification of the binding properties of muscarinic receptors by gallamine.
    Stockton JM; Birdsall NJ; Burgen AS; Hulme EC
    Mol Pharmacol; 1983 May; 23(3):551-7. PubMed ID: 6865905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical characterization of the muscarinic cholinergic receptor in human brain: alterations in Huntington's disease.
    Wastek GJ; Yamamura HI
    Mol Pharmacol; 1978 Sep; 14(5):768-80. PubMed ID: 152407
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of muscarinic binding sites in human neutrophils by direct binding.
    Dulis BH; Gordon MA; Wilson IB
    Mol Pharmacol; 1979 Jan; 15(1):28-34. PubMed ID: 423890
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the rate of occupancy of receptors by anti-cholinergic drugs.
    Gilani AU
    Biochem Soc Trans; 1990 Apr; 18(2):289-90. PubMed ID: 2379722
    [No Abstract]   [Full Text] [Related]  

  • 38. [Difference in the muscarinolytic activity of antagonists in relation to the muscarinic cholinoreceptors of various organs in one species of animal].
    Godovikov NN; Dorofeeva NA; Kabachnik MI; Kardanov NA; Trifonova SA
    Dokl Akad Nauk SSSR; 1985; 284(2):503-5. PubMed ID: 4053964
    [No Abstract]   [Full Text] [Related]  

  • 39. Central muscarinic receptor degeneration following 6-hydroxydopamine lesion in mice.
    Gurwitz D; Kloog Y; Egozi Y; Sokolovsky M
    Life Sci; 1980 Jan; 26(1):79-84. PubMed ID: 7360000
    [No Abstract]   [Full Text] [Related]  

  • 40. Anticholinergic activity of bornaprine and its metabolites in the isolated rat atrium.
    Hufford CD; Elmarakby SA; Walker LA
    Pharmacology; 1991; 42(1):23-7. PubMed ID: 2057518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.